Mineralys Therapeutics, Inc.
USD27.04
+0.16 (+0.60%)
CEO
Jon Congleton
IPO Date
2023-02-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.82
Prev. Close
$26.88
Day Low
$25.56
Day High
$27.08
52W Low
$12.59
52W High
$47.65
Market Cap
$1.79B
Volume
0.83M
| -3.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -29.8% | -28.6% | 0.00 | 23.76 | -4.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 57.0% | -26.0% | 0.00 | 13.98 | -3.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 84.7% | -174.5% | 0.00 | 2.20 | -4.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 95.2% | -230.6% | -1.25 | 0.29 | -24.9 |
| -22.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.4% | -6.2% | 0.00 | 25.50 | -18.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -13.8% | -12.9% | 0.00 | 15.12 | -5.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -12.4% | -11.9% | 0.00 | 26.48 | -5.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -25.6% | -23.8% | 0.00 | 14.02 | -3.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -23.8% | -21.0% | 0.00 | 8.55 | -2.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -14.1% | -12.9% | 0.00 | 11.20 | -3.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -9.6% | -9.1% | 0.00 | 18.06 | -4.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -10.1% | -9.7% | 0.00 | 23.76 | -3.5 |